4月3日 - ** 生物技术公司 Virpax Pharmaceuticals VRPX.O 股价下跌 55.2% 至 54 美分
** VRPX 的股票明天将从纳斯达克退市 (link)，原因是未能达到最低股东权益要求--美国证券交易委员会文件
** 公司不打算对退市决定提出上诉
** 三名董事会成员和首席财务官 Usama Chaudhry 辞职，立即生效
** 包括本交易日在内，公司股价今年累计下跌 94
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.